Validation of the IMPEDE VTE Score for Prediction of Venous Thromboembolism in Multiple Myeloma: A Retrospective Cohort Study

Alex V. Mejia Garcia

Validation of the IMPEDE VTE Score for Prediction of Venous Thromboembolism in Multiple Myeloma: A Retrospective Cohort Study

Alex V. Mejia Garcia

Baptist Health South Florida

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	British Journal of Haematology
Volume	193
State	Published - 2021

Disciplines

Medicine and Health Sciences

Cite this

@article{b8a3f8af7b674d5c8c001dc0520a07db,

title = "Validation of the IMPEDE VTE Score for Prediction of Venous Thromboembolism in Multiple Myeloma: A Retrospective Cohort Study",

author = "\{Mejia Garcia\}, \{Alex V.\}",

note = "The IMPEDE VTE score has recently emerged as a novel risk prediction tool for venous thromboembolism (VTE) in multiple myeloma (MM). We retrospectively reviewed 839 patients with newly diagnosed MM between 2010 and 2015 at Cleveland Clinic and included 575 patients in final analysis to validate this ...",

year = "2021",

language = "American English",

volume = "193",

journal = "British Journal of Haematology",

}

TY - JOUR

T1 - Validation of the IMPEDE VTE Score for Prediction of Venous Thromboembolism in Multiple Myeloma: A Retrospective Cohort Study

AU - Mejia Garcia, Alex V.

N1 - The IMPEDE VTE score has recently emerged as a novel risk prediction tool for venous thromboembolism (VTE) in multiple myeloma (MM). We retrospectively reviewed 839 patients with newly diagnosed MM between 2010 and 2015 at Cleveland Clinic and included 575 patients in final analysis to validate this ...

PY - 2021

Y1 - 2021

UR - https://pubmed.ncbi.nlm.nih.gov/33997961/

M3 - Article

VL - 193

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -

Validation of the IMPEDE VTE Score for Prediction of Venous Thromboembolism in Multiple Myeloma: A Retrospective Cohort Study

Disciplines

Other files and links

Cite this